in-vitro fertilization
Conditions
Interventions
Sponsors
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women screened positive for HBsAg prior to IVF treatment;Inclusion criteria: Women screened positive for HBsAg prior to IVF treatment
Exclusion criteria
Exclusion criteria: Women with clinical manifestation of Hepatitis B infection, with other blood borne infection including Hepatits C, HIV, syphilis, partner is also a hepatitis B carrier and those who unable to give consent or refuse to participate in the study.;Exclusion criteria: Women with clinical manifestation of Hepatitis B infection, with other blood borne infection including Hepatits C, HIV, syphilis, partner is also a hepatitis B carrier and those who unable to give consent or refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clincal pregnancy rate Follicular fluid HBV DNA level;;Clincal pregnancy rate Follicular fluid HBV DNA level; | — |
Countries
China
Contacts
Public ContactDr Mak Sze Man Jennifer;Dr Mak Sze Man Jennifer ;
The Chinese University of Hong Kong;The Chinese University of Hong Kong
Outcome results
None listed